Install
Vaccines & Immunology
mRNA platforms, boosters, monoclonals, and immune‑system science.
- 18 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
Latest in Vaccines & Immunology
Q&A: Advancing cancer biotech therapies with a multipronged approach
13+ min ago (562+ words) Op-Ed: Space weaponization could be an incredibly stupid, massive own goal for humanity Middle East cyber threats enter a new phase as ransomware surges and AI joins the attacker’s toolkit Canadian organizations are struggling to turn AI into ROI Foldable…...
WBS Activity Coding Structure Simplifies Primavera P6 Schedules｜Himansi Kaur
1+ day, 13+ hour ago (184+ words) In Primavera P6, activity code refers to a label which is assigned to an activity. This label is based on a specific classification. For example, a building project may contain activities for excavation, foundations, structural work, electrical installation, and finishing. Without…...
Tiny particles turn a tumor’s own immune guards against it
18+ hour, 53+ min ago (957+ words) Nanoparticles that reprogram a tumor's own macrophages drew killer T cells into mouse breast tumors, a new route for cancer immunotherapy. The immune system may be capable of attacking a tumor. Yet some of the most common cells inside a…...
Too Much RNA Can Drain a Cell’s Energy, Scientists Discover
1+ day, 2+ hour ago (590+ words) A virus may cripple a cell’s power supply simply by producing too much of a molecule the cell needs to survive....
CAR-T Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
2+ day, 2+ hour ago (60+ words) CAR-T Clinical Trial Pipeline Gains Momentum: 180+ Companies openPR.com CAR-T Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight Press release from: ABNewswire Permanent link to this press release: You can edit or delete your…...
Novosibirsk firm Vector-BiAlgam secures patent for faster hepatitis A vaccine process | News
2+ day, 6+ hour ago (286+ words) As the developers explained, existing methods lose up to 70–90% of antigen during purification, and its closest prototype – the Algavak vaccine – does not provide sufficient purification from cellular DNA and ballast proteins while maintaining the required antigen yield. According to them,…...
Building Virtual Tumors to Crack Cancer's Resistance to Immunotherapy - USC Viterbi | School of Engineering
1+ day, 23+ hour ago (699+ words) BME50 – A USC Viterbi bioengineer is building digital tumors, cell by cell, with a goal that could change how oncologists treat breast cancer: knowing in advance which patients immunotherapy will actually help. “The immune cells should be killing the cancer cells,…...
Cancer Cells Use a "Sugar Shield" to Hide From the Immune System. Scientists Found a Way to Target It
2+ day, 11+ hour ago (721+ words) Cancer cells have developed numerous ways to hide from the immune system. One of the strangest may be written in sugar. Every cell in the human body is covered in a dense layer of sugar-containing molecules called glycans. These aren’t…...
AI is helping develop new vaccines
2+ day, 15+ hour ago (839+ words) n the early 2000s, immunologist Bali Pulendran started his lab at Emory University to explore the mechanisms underlying vaccine-mediated...
Making Invisible Cancers Visible: Study Suggests a New Route to Turn ‘Cold’ Tumors ‘Hot’ | Newswise
2+ day, 18+ hour ago (192+ words) The paper was published in Immunity. “Immunotherapy cannot attack what the immune system cannot see,” said Ellis L. Reinherz, MD, chief of the Laboratory of Immunotherapy at Dana-Farber and professor of medicine at Harvard Medical School, a co-supervising author of…...